SCHEMBL4431369

SCHEMBL4431369

CC(=O)C(c1ccc(C(F)(F)F)cc1)c1cccc(OC(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PPARG P37231 7/20 0.41
MAOB P27338 1/20 0.41
PPARA Q07869 2/20 0.40
POLB P06746 1/20 0.39
TACR1 P25103 2/20 0.39
SLC22A12 Q96S37 1/20 0.38
SLC6A9 P48067 1/20 0.38
FFAR1 O14842 2/20 0.38
ACP3 P15309 1/20 0.38
OPRK1 P41145 1/20 0.37
HDAC4 P56524 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432452 0.84 P2RX7 (0.40) MEN1LMNAHTTKMT2ASMN1; SMN2
SCHEMBL4438527 0.83 CES2 (0.50) MEN1KMT2ASMN1; SMN2NPSR1POLB
SCHEMBL4431032 0.83 PDE4A (0.45) MEN1LMNAHTTKMT2ASMN1; SMN2
SCHEMBL2304585 0.80 ACP3 (0.56) TACR1ACP3
SCHEMBL11103452 0.76 ACP3 (0.55) MEN1HTTKMT2ASMN1; SMN2MAPT
SCHEMBL4431561 0.75 AKR1C3 (0.48) TACR1HDAC4
SCHEMBL4432335 0.75 CES2 (0.41) MAPTPPARGPPARATACR1ACP3
SCHEMBL4434672 0.74 PPARG (0.41) MEN1LMNAHTTKMT2ASMN1; SMN2
SCHEMBL4433608 0.74 P2RX7 (0.40) FFAR1
SCHEMBL4434628 0.74 AKR1C3 (0.51) MEN1KMT2AMAPTPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed